Brigham and Women's Hospital, Department of Medicine, Boston, Massachusetts, USA
Harvard School of Public Health, Department of Health Policy and Management, Boston, Massachusetts, USA.
BMJ Qual Saf. 2019 Nov;28(11):e1. doi: 10.1136/bmjqs-2018-008087. Epub 2018 Sep 26.
Inter-hospital transfer (IHT, the transfer of patients between hospitals) occurs regularly and exposes patients to risks of discontinuity of care, though outcomes of transferred patients remains largely understudied.
To evaluate the association between IHT and healthcare utilisation and clinical outcomes.
Retrospective cohort.
CMS 2013 100 % Master Beneficiary Summary and Inpatient claims files merged with 2013 American Hospital Association data.
Beneficiaries≥age 65 enrolled in Medicare A and B, with an acute care hospitalisation claim in 2013 and 1 of 15 top disease categories.
Cost of hospitalisation, length of stay (LOS) (of entire hospitalisation), discharge home, 3 -day and 30- day mortality, in transferred vs non-transferred patients.
The final cohort consisted of 53 420 transferred patients and 53 420 propensity-score matched non-transferred patients. Across all 15 disease categories, IHT was associated with significantly higher costs, longer LOS and lower odds of discharge home. Additionally, IHT was associated with lower propensity-matched odds of 3-day and/or 30- day mortality for some disease categories (acute myocardial infarction, stroke, sepsis, respiratory disease) and higher propensity-matched odds of mortality for other disease categories (oesophageal/gastrointestinal disease, renal failure, congestive heart failure, pneumonia, renal failure, chronic obstructivepulmonary disease, hip fracture/dislocation, urinary tract infection and metabolic disease).
In this nationally representative study of Medicare beneficiaries, IHT was associated with higher costs, longer LOS and lower odds of discharge home, but was differentially associated with odds of early death and 30 -day mortality depending on patients' disease category. These findings demonstrate heterogeneity among transferred patients depending on the diagnosis, presenting a nuanced assessment of this complex care transition.
医院间转院(患者在医院之间的转院)经常发生,使患者面临护理连续性中断的风险,尽管转院患者的结局在很大程度上仍未得到充分研究。
评估医院间转院与医疗保健利用和临床结局之间的关联。
回顾性队列研究。
CMS 2013 100%主受益人摘要和住院索赔文件与 2013 年美国医院协会数据合并。
年龄≥65 岁的 Medicare A 和 B 参保者,2013 年有急性住院治疗索赔和 15 种主要疾病类别之一。
转院与非转院患者的住院费用、住院时间(LOS)(整个住院时间)、出院回家、3 天和 30 天死亡率。
最终队列包括 53420 例转院患者和 53420 例倾向评分匹配的非转院患者。在所有 15 种疾病类别中,医院间转院与显著更高的费用、更长的 LOS 和更低的出院回家几率相关。此外,对于某些疾病类别(急性心肌梗死、中风、脓毒症、呼吸疾病),医院间转院与倾向评分匹配的 3 天和/或 30 天死亡率降低的几率相关,而对于其他疾病类别(食管/胃肠道疾病、肾衰竭、充血性心力衰竭、肺炎、肾衰竭、慢性阻塞性肺疾病、髋关节骨折/脱位、尿路感染和代谢疾病),医院间转院与倾向评分匹配的死亡率升高的几率相关。
在这项针对 Medicare 受益人的全国代表性研究中,医院间转院与更高的费用、更长的 LOS 和更低的出院回家几率相关,但与早期死亡和 30 天死亡率的几率因患者的疾病类别而异而相关。这些发现表明转院患者存在异质性,具体取决于诊断,这对这种复杂的医疗转院情况进行了细致的评估。